Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy
about
Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potentialTarget therapy in metastatic pheochromocytoma: current perspectives and controversiesPP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia.Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair.PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repairThe protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicityCeramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo.Pheochromocytoma - update on disease management.18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors.Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cellsRadiation induces premature chromatid separation via the miR-142-3p/Bod1 pathway in carcinoma cellsRoles and regulation of protein phosphatase 2A (PP2A) in the heart.
P2860
Q26828446-82F8617F-B508-49E4-BDBA-B96D94A5E697Q26865711-8784BDC5-876A-4922-A995-96A35FDE59A0Q28087343-E34A4597-7094-4C41-9CED-D78E2CB61906Q33767159-F357A218-D237-4718-9545-EDCC9358A598Q34130984-A50D8D4B-6D42-4088-B2E3-02D2BF5DBA81Q34365755-C6EC5165-4A62-450A-8618-3ED92EF2DC1EQ34504365-031004CF-064A-4453-B1AD-26E3360B4ED8Q34777845-56DC0BA3-B826-423A-AEB9-4B638760F417Q36019903-9D190323-FCF9-429D-B29D-D99A473F774BQ36186252-2D426D4D-C457-442F-B79B-42422F8EAFFCQ36328071-40446DF8-6897-47C4-9DB5-38DEFABA7915Q36342833-2E69DD19-1E3C-423B-91B7-D2C8B7A97C94Q36625228-AEF8EB73-B287-4D27-AD08-76F6E9E3A028Q36948906-7E8F8BA4-14F3-4C9D-8BC2-7944E365F5B1Q37645037-24B94433-57AC-4CD8-B1AB-6FE32ECD66C8Q39004833-E5781073-8305-46CC-AD74-730099BF69E2
P2860
Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacologic modulation of se ...... l to conventional chemotherapy
@ast
Pharmacologic modulation of se ...... l to conventional chemotherapy
@en
Pharmacologic modulation of se ...... l to conventional chemotherapy
@nl
type
label
Pharmacologic modulation of se ...... l to conventional chemotherapy
@ast
Pharmacologic modulation of se ...... l to conventional chemotherapy
@en
Pharmacologic modulation of se ...... l to conventional chemotherapy
@nl
prefLabel
Pharmacologic modulation of se ...... l to conventional chemotherapy
@ast
Pharmacologic modulation of se ...... l to conventional chemotherapy
@en
Pharmacologic modulation of se ...... l to conventional chemotherapy
@nl
P2093
P2860
P921
P1433
P1476
Pharmacologic modulation of se ...... l to conventional chemotherapy
@en
P2093
Jeffrey Chiang
Lucia Martiniova
Marcelino Bernardo
Russell Lonser
Zhengping Zhuang
P2860
P304
P356
10.1371/JOURNAL.PONE.0014678
P407
P50
P577
2011-02-14T00:00:00Z